Healthcare - Biotechnology - NASDAQ - US
$ 15.92
-3.46 %
$ 1.24 B
Market Cap
-6.77
P/E
CASH FLOW STATEMENT
-125 M
OPERATING CASH FLOW
15.6 M
INVESTING CASH FLOW
94.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Kura Oncology, Inc.
| Net Income | -153 M |
| Depreciation & Amortization | 849 K |
| Capital Expenditures | -168 K |
| Stock-Based Compensation | 28.1 M |
| Change in Working Capital | 7.82 M |
| Others | -1.12 M |
| Free Cash Flow | -125 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||||||
| Net Income | (152.6) | (135.8) | (130.5) | (89.6) | (63.1) | (60.4) | (35.4) | (27.6) | (22.6) | 11 K | 27.3 K | 27 K | 22.4 K | 22.4 K | 0 | 0 |
| Depreciation & Amortization | 0.8 | 0.8 | 0.6 | 0.2 | 0 | 10 K | 30 K | 31 K | 20 K | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax | 0 | 0 | 4.6 | 0 | 0 | (1.4) | (0.3) | 0.1 | 0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 28.1 | 26.3 | 23.6 | 12.8 | 9.4 | 8.7 | 4.5 | 2.1 | 2.3 | 711 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | (8.9) | 1.7 | 0.4 | 0.4 | (1.1) | 0.2 | 0.1 | 42 K | 0.6 | 4.4 K | 11.3 K | 31.7 K | 69.3 K | 625 | 0 | 0 |
| Change in Working Capital | 7.8 | (3.0) | (3.2) | 6.4 | 74 K | 4.4 | 2.6 | 80 K | 1.4 | 3.35 K | 8.44 K | 27.3 K | 66.1 K | 3.78 K | 0 | 0 |
| Cash From Operations | (124.8) | (110.1) | (104.6) | (69.8) | (54.8) | (48.7) | (28.4) | (25.3) | (17.9) | 2.55 K | 24.4 K | 22.7 K | 19.2 K | 19.2 K | 21.4 K | 31.8 K |
| INVESTING CASH FLOW | ||||||||||||||||
| Capital Expenditures | (0.2) | (0.6) | (1.1) | (2.2) | 0 | 0 | 0 | 0 | 64 K | 84 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Items | 15.7 | 33.3 | (125.7) | (97.8) | (46.3) | (79.3) | (23.4) | 12.2 | (70.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 15.6 | 32.6 | (126.8) | (99.9) | (46.3) | (79.3) | (23.4) | 12.2 | (70.6) | 84 | 0 | 0 | 0 | 0 | 0 | 0 |
| FINANCING CASH FLOW | ||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 K | 6.57 K | 4.8 K | 4.22 K | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 10.0 | (7.2) | (0.2) | 0 | (0.6) | 0 | 7.5 | 5.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.2 | 3.8 | (0.6) | 10.2 | 2.9 | 1.1 | 53.6 | 0 | 0 | 2.0 | 25 K | 25 K | 35 K | 35 K | 25 K | 0 |
| Cash From Financing Activities | 94.8 | 38.6 | (3.4) | 469.3 | 111.1 | 132.6 | 53.6 | 7.5 | 102.9 | 6 K | 25 K | 25 K | 35 K | 35 K | 25 K | 0 |
| CHANGE IN CASH | ||||||||||||||||
| Net Change In Cash | (14.5) | (38.9) | (234.8) | 299.6 | 10.0 | 4.7 | 1.7 | (5.7) | 14.3 | 1.1 | 582 | 22.7 K | 15.8 K | 15.8 K | 3.63 K | 31.8 K |
| FREE CASH FLOW | ||||||||||||||||
| Free Cash Flow | (125.0) | (110.7) | (105.7) | (72.0) | (54.8) | (48.7) | (28.4) | (25.3) | (18.0) | 2.63 K | 24.4 K | 22.7 K | 19.2 K | 19.2 K | 21.4 K | 31.8 K |